During the past decade, Duke Early Phase Clinical Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Duke Early Phase Clinical Research" #1 sponsor was "Eiger BioPharmaceuticals" with 1 trials, followed by "Elysium Health" with 1 trials sponsored, "National Institute of Mental Health (NIMH)" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Pharmos" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke Early Phase Clinical Research" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Duke Early Phase Clinical Research" are "Acute Mountain Sickness and Fatigue" (1 trials), "Clostridium Difficile Infection" (1 trials), "Epigenetics" (1 trials), "Gout" (1 trials) and "Hyperinsulinemic Hypoglycemia" (1 trials). Many other conditions were trialed in "Duke Early Phase Clinical Research" in a lesser frequency.

Most popular intervention types in "Duke Early Phase Clinical Research" are "Drug" (5 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "(2R,6R)-Hydroxynorketamine hydrochloride" (1 trials), "Ambrisentan 5 mg" (1 trials), "Aminophylline 400 mg" (1 trials) and "Biomarker study" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duke Early Phase Clinical Research" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Duke Early Phase Clinical Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Duke Early Phase Clinical Research, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Duke Early Phase Clinical Research, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".